Difference between revisions of "Team:Sheffield/Integrated Practices"
| Line 301: | Line 301: | ||
We did not simply make conclusions on the stakeholders’ needs through researching secondary sources but actually went out and spoke to different stakeholders personally. | We did not simply make conclusions on the stakeholders’ needs through researching secondary sources but actually went out and spoke to different stakeholders personally. | ||
</P> | </P> | ||
| − | + | <!-- | |
<p> | <p> | ||
We first got in touch with <b>Professor Milton Wainwright, author of “Miracle Cure: The Story of Penicillin and the Golden Age of Antibiotics” </b>, to understand the history of antibiotics and <b> Dr. Jolian McHardy, an Economics lecturer at the University of Sheffield </b>, to learn the economics of misusing antibiotics. These conversations allowed us to have better knowledge on antibiotic resistance. | We first got in touch with <b>Professor Milton Wainwright, author of “Miracle Cure: The Story of Penicillin and the Golden Age of Antibiotics” </b>, to understand the history of antibiotics and <b> Dr. Jolian McHardy, an Economics lecturer at the University of Sheffield </b>, to learn the economics of misusing antibiotics. These conversations allowed us to have better knowledge on antibiotic resistance. | ||
| Line 317: | Line 317: | ||
Furthermore, potential end users of our device also include animals. <b>Professor Andrew Rycroft, Professor and Veterinarian at the Royal Veterinary College</b>, provided us an interesting insight on the design of this device and the scope of the veterinary use of antibiotics. | Furthermore, potential end users of our device also include animals. <b>Professor Andrew Rycroft, Professor and Veterinarian at the Royal Veterinary College</b>, provided us an interesting insight on the design of this device and the scope of the veterinary use of antibiotics. | ||
</P> | </P> | ||
| + | --> | ||
<p> | <p> | ||
We did more than just interview experts and stakeholders. To explore how we expanded and see how we integrated stakeholders’ opinions in the design of our project, please see the sections below. </p> | We did more than just interview experts and stakeholders. To explore how we expanded and see how we integrated stakeholders’ opinions in the design of our project, please see the sections below. </p> | ||
Revision as of 15:34, 17 October 2016
|
HUMAN PRACTICES |
|
|---|
Overview
Our work in human practices is set out to study the societal implications of our project. The findings informed our understanding of antibiotic resistance as a problem. Most importantly, this was then used to improve the design of our project beyond a pure biological and engineering point of view, but from a point of view of the stakeholders. We achieve this by modifying our design to their needs.
We did not simply make conclusions on the stakeholders’ needs through researching secondary sources but actually went out and spoke to different stakeholders personally.
We did more than just interview experts and stakeholders. To explore how we expanded and see how we integrated stakeholders’ opinions in the design of our project, please see the sections below.
